Laboratory Vacuum Pumps Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

The Global Laboratory Vacuum Pumps Market was valued at USD 1.9 billion in 2025 and is estimated to grow at a CAGR of 6.5% to reach USD 3.5 billion by 2035.

The market growth is supported by rising demand for advanced laboratory infrastructure, increasing diagnostic activities in healthcare, and expanding pharmaceutical and biotechnology research operations. Laboratory vacuum pumps are critical equipment designed to generate controlled vacuum conditions that support various laboratory procedures, including filtration, drying, distillation, and analytical processes. These systems are extensively used across pharmaceutical production, biotechnology applications, clinical testing facilities, and research institutions. Laboratory vacuum pumps are available in dry and wet configurations and incorporate technologies such as rotary vane, screw, claw, and diaphragm mechanisms to address diverse operational requirements. The increasing requirement for sophisticated medical and analytical equipment that depends on vacuum technology is contributing to market expansion. Additionally, the growing number of diagnostic laboratories, driven by higher disease prevalence, increasing emphasis on early detection, and rising adoption of preventive healthcare practices, is strengthening demand for reliable laboratory vacuum systems. The continued development of independent diagnostic facilities, hospital laboratories, and specialized testing centers is increasing laboratory workloads and encouraging investments in efficient vacuum equipment.

The dry vacuum pumps segment accounted for 59.7% share in 2025, supported by advantages such as cleaner operation, reduced maintenance needs, and improved energy efficiency in laboratory settings. Dry vacuum pumps are increasingly preferred across pharmaceutical, biotechnology, and research environments because they operate without oil or liquid-based sealing systems, reducing contamination risks during sensitive procedures. Their ability to maintain high-purity conditions makes them suitable for applications requiring controlled environments and precise performance. The rising demand for reliable laboratory processes, combined with strict quality requirements in life science and analytical applications, continues to encourage the adoption of dry vacuum pump technologies.

The pharmaceutical and biotechnology companies segment generated USD 927.1 million in 2025. The segment's strong position is attributed to the widespread use of vacuum systems throughout pharmaceutical research, drug development, and manufacturing activities. These companies depend on laboratory vacuum pumps for processes requiring accurate pressure management and contamination-free conditions. Growing investments in advanced therapies, biologics, and biosimilar development are further increasing the need for high-performance vacuum equipment capable of supporting complex laboratory operations.

U.S. Laboratory Vacuum Pumps Market was valued at USD 735.2 million in 2025. The North America laboratory vacuum pumps market is being supported by strong pharmaceutical and biotechnology research activities, along with a well-established life sciences ecosystem and continuous investment in scientific innovation. The region includes a large base of pharmaceutical companies, biotechnology organizations, and research centers involved in drug development, advanced healthcare research, and laboratory-based innovation. These activities require highly controlled laboratory environments where vacuum pumps are essential for procedures such as sample preparation, filtration, and solvent processing.

Key companies operating in the global laboratory vacuum pumps industry include Agilent, BUSCH, Atlas Copco, EDWARDS, KNF, ULVAC, Leybold, VACUUBRAND, Graham, PFEIFFER, SHIMADZU, Ebara Technologies, DEKKER, gast, and WELCH. Companies operating in the laboratory vacuum pumps market are strengthening their market position through product innovation, technology upgrades, strategic partnerships, and expansion into emerging application areas. Manufacturers are focusing on developing energy-efficient, low-maintenance, and contamination-resistant vacuum solutions to meet the evolving needs of pharmaceutical, biotechnology, and research laboratories. Businesses are also investing in advanced engineering capabilities to improve pump performance, durability, and operational efficiency. Strategic collaborations with research organizations and end users help companies understand changing laboratory requirements and develop application-specific solutions.